Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antiasthma Drugs: β2-Adrenoceptor Agonists01:25

Antiasthma Drugs: β2-Adrenoceptor Agonists

1.6K
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
1.6K
Inhaled Medications01:23

Inhaled Medications

687
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
687
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

3.0K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.0K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

1.7K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.7K
Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

1.7K
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
1.7K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

1.2K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.2K
  1. Home
  3. Research Domains
  5. Engineering
  7. Materials Engineering
  9. Wearable Materials
  11. Clinical Implications Of Mechanical And Adhesive Differences Between Branded And Generic Tulobuterol Patches In Asthma Management

Clinical Implications of Mechanical and Adhesive Differences Between Branded and Generic Tulobuterol Patches in Asthma Management

Atsushi Ishimura1, HIna Tabayashi1, Motoki Inoue2

  • 1Laboratory of Clinical Pharmacy Assessment, Hoshi University, Shinagawa, JPN.

Cureus
|December 15, 2025

Related Experiment Videos

Author Spotlight: Efficacy of Auricular Pressure Bean Therapy in Reducing Wheezing Symptoms
02:34

Author Spotlight: Efficacy of Auricular Pressure Bean Therapy in Reducing Wheezing Symptoms

Published on: May 10, 2024

1.8K
Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
14:39

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 4, 2010

32.4K
Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
07:28

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System

Published on: April 6, 2017

41.4K

View abstract on PubMed

Summary
This summary is machine-generated.

Generic and branded tulobuterol transdermal patches for asthma show significant differences in mechanical and adhesive properties. These variations, driven by excipient composition, may impact usability and patient adherence to treatment.

Area of Science:

  • Pharmacology
  • Materials Science
  • Drug Delivery Systems

Background:

  • Tulobuterol transdermal patches are widely used for asthma management in Japan.
  • Understanding formulation differences between branded and generic patches is crucial for ensuring therapeutic equivalence and patient compliance.
  • Excipient composition significantly influences the physical properties and performance of transdermal drug delivery systems.

Purpose of the Study:

  • To evaluate and compare the mechanical and adhesive properties of a branded tulobuterol patch and six generic alternatives.
  • To investigate the impact of excipient composition on the usability and performance of tulobuterol transdermal patches.
  • To correlate formulation differences with observed variations in patch characteristics.

Main Methods:

Keywords:
adhesive propertyasthma managementgeneric drugmechanical testing

Related Experiment Videos

Author Spotlight: Efficacy of Auricular Pressure Bean Therapy in Reducing Wheezing Symptoms
02:34

Author Spotlight: Efficacy of Auricular Pressure Bean Therapy in Reducing Wheezing Symptoms

Published on: May 10, 2024

1.8K
Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
14:39

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 4, 2010

32.4K
Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
07:28

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System

Published on: April 6, 2017

41.4K
  • Analysis of one branded and six generic tulobuterol transdermal patches.
  • Mechanical strength assessment using uniaxial tensile testing.
  • Adhesive performance (tackiness) evaluation via spherical probe detachment test under controlled environmental conditions (25°C, 60% RH).
  • Identification of excipient compositions from publicly available package inserts.

    • Main Results:

    • Significant formulation-dependent differences were observed in both mechanical and adhesive properties.
    • The branded patch exhibited rigidity, rupturing early under stress, while several generics showed greater flexibility.
    • Tackiness varied widely among generics, with some displaying excessive adhesion and others insufficient tackiness, correlating with adhesive polymers and plasticizers.

    Conclusions:

    • Branded and generic tulobuterol transdermal patches possess distinct mechanical and adhesive characteristics, despite equivalent pharmacokinetic profiles.
    • These differences, stemming from excipient variations, may affect clinical usability and patient adherence in asthma management.
    • The study highlights the importance of considering excipient-driven performance variations when selecting transdermal asthma medications.
    pharmaceutical formulation
    transdermal drug delivery
    tulobuterol patch